Ane Ogbe

University of Oxford - Peter Medawar Building for Pathogen Research

South Parks Road

OX2 3SY

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS
Rank 18,318

SSRN RANKINGS

Top 18,318

in Total Papers Downloads

3,284

SSRN CITATIONS

4

CROSSREF CITATIONS

0

Scholarly Papers (2)

T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study

Number of pages: 55 Posted: 25 Mar 2021
University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - HPRU in Emerging and Zoonotic Infections, Newcastle University - Translational and Clinical Research Institute, University of Oxford - Sir William Dunn School of Pathology, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Liverpool - HPRU in Emerging and Zoonotic Infections, Sheffield Teaching Hospitals NHS Foundation Trust, University of Liverpool - HPRU in Emerging and Zoonotic Infections, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Nuffield Department of Clinical Neurosciences, Public Health England Colindale, University of Liverpool - HPRU in Emerging and Zoonotic Infections, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Newcastle University - Translational and Clinical Research Institute, Newcastle University - Translational and Clinical Research Institute, Newcastle University - Translational and Clinical Research Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, University of Oxford - Department of Paediatrics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Public Health England Colindale, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Public Health England Colindale, University of Oxford - Sir William Dunn School of Pathology, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Birmingham - Clinical Immunology Service, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Wellcome Centre for Human Genetics, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Sheffield Teaching Hospitals NHS Foundation Trust - South Yorkshire Regional Department of Infection and Tropical Medicine and affiliation not provided to SSRN
Downloads 2,699 (5,597)
Citation 1

Abstract:

Loading...

T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study

Number of pages: 55 Posted: 13 Apr 2021
University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool - HPRU in Emerging and Zoonotic Infections, Newcastle University - Translational and Clinical Research Institute, University of Oxford - Sir William Dunn School of Pathology, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Liverpool - HPRU in Emerging and Zoonotic Infections, Sheffield Teaching Hospitals NHS Foundation Trust, University of Oxford - Nuffield Department of Clinical Neurosciences, Public Health England Colindale, University of Liverpool - HPRU in Emerging and Zoonotic Infections, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Newcastle University - Translational and Clinical Research Institute, Newcastle University - Translational and Clinical Research Institute, Newcastle University - Translational and Clinical Research Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, Sheffield Teaching Hospitals NHS Foundation Trust, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, University of Oxford - Department of Paediatrics, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Public Health England Colindale, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, Public Health England Colindale, University of Oxford - Sir William Dunn School of Pathology, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Birmingham - Clinical Immunology Service, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Wellcome Centre for Human Genetics, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Sheffield Teaching Hospitals NHS Foundation Trust - South Yorkshire Regional Department of Infection and Tropical Medicine and affiliation not provided to SSRN
Downloads 317 (116,605)

Abstract:

Loading...

2.

Safety and Immunogenicity of the ChAdox1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 in HIV Infection

Number of pages: 39 Posted: 19 Apr 2021
University of Oxford, University of Oxford - Jenner Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, NIHR Imperial Clinical Research Facility, University of Oxford - The Jenner Institute, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - The Jenner Institute, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Jenner Institute, University of Oxford - The Jenner Institute, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University College London - Department of Infection, University of Oxford - Jenner Institute, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - The Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Peter Medawar Building for Pathogen Research, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, NIHR Imperial Clinical Research Facility, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Oxford Vaccine Group, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Peter Medawar Building for Pathogen Research, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, NIHR Guy's and St Thomas' Biomedical Research Centre, Imperial College London - Department of Infectious Disease, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Oxford Vaccine Group, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, University of Oxford - Peter Medawar Building for Pathogen Research, Oxford University Hospitals NHS Foundation Trust, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford - Department of Paediatrics, University of Oxford - Peter Medawar Building for Pathogen Research, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, Imperial College London - Department of Infectious Disease, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - The Jenner Institute, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Medicine, Guy's and St Thomas' NHS Foundation Trust - Harrison Wing, University of Oxford - Jenner Institute and affiliation not provided to SSRN
Downloads 268 (141,390)

Abstract:

Loading...